Access BayerPRO
Ask a Question
Therapeutic Area
Content
BAYERMED
Your Scientific Resource Portal
Therapeutic Area
CHRONIC KIDNEY DISEASE
Disease & Awareness
Events
Learning Materials
Medical Literature
CONTRACEPTION
Learning Materials
Clinical Tools
HEART FAILURE
Events
Medical Literature
HEMOPHILIA
Learning Materials
MENOPAUSE
Awareness
Learning Materials
OPHTHALMOLOGY
Learning Materials
Medical Literature
PROSTATE CANCER
Clinical Tools
Events
Learning Materials
Medical Literature
Content
CLINICAL TOOLS
Contraception
Prostate Cancer
DISEASE & AWARENESS
Chronic Kidney Disease
Menopause
EVENTS
Chronic Kidney Disease
Heart Failure
Prostate Cancer
LEARNING MATERIALS
Chronic Kidney Disease
Contraception
Hemophilia
Menopause
Ophthalmology
Prostate Cancer
MEDICAL LITERATURE
Chronic Kidney Disease
Heart Failure
Ophthalmology
Prostate Cancer
EN
EN - English
FR - French
Log In
Clinical Tools Recent Updates
PCS-X
Management of Oligoprogressive Castration Resistant Prostate Cancer (PCS X)
AlphaBet
Combination of Radium-223 and Lutetium-177 PSMA-I&T in Men with Metastatic Castration-Resistant Prostate Cancer (AlphaBet)
DASL-HiCaP
Darolutamide Augments Standard Therapy for Localised Very High-Risk Cancer of the Prostate (DASL-HiCaP)
RAVENS
RAdium-223 and SABR Versus SABR for Oligometastatic Prostate Cancers (RAVENS)
Product Monograph
Monographie de produit du radium-223
Obtenez la version la plus récente de la monographie de produit du radium-223.
Monographie de produit du darolutamide
Obtenez la version la plus récente de la monographie de produit du darolutamide.
Darolutamide Clinical Trials
DASL-HiCaP
Darolutamide Augments Standard Therapy for Localised Very High-Risk Cancer of the Prostate (DASL-HiCaP)
ARASTEP
A Study to Compare Darolutamide Given With Androgen Deprivation Therapy (ADT) With ADT in Men With Hormone Sensitive Prostate Cancer and ...
DAROL
A Study in Which Non-metastatic Castration-resistant Prostate Cancer (nmCRPC) Patients for Whom a Decision to Treat With Darolutamide Has...
PCS-X
Management of Oligoprogressive Castration Resistant Prostate Cancer (PCS X)
Radium-223 Clinical Trials
View more
DORA
A Study to Test Radium-223 With Docetaxel in Patients With Prostate Cancer
RADIANT
Investigation of Radium-223 Dichloride (Xofigo), a Treatment That Gives Off Radiation That Helps Kill Cancer Cells, Compared to a Treatme...
RAVENS
RAdium-223 and SABR Versus SABR for Oligometastatic Prostate Cancers (RAVENS)
RAPSON
Sequencing of Radium-223 and Docetaxel in Symptomatic Bone-only Metastatic Castration-resistant Prostate Cancer (RAPSON)
Actinium-225 Clinical Trials
PAnTHA (225Ac-PSMA-Trillium)
First-in-human Study of 225Ac-PSMA-Trillium (BAY 3563254) in Participants With Advanced Metastatic Castration-resistant Prostate Cancer (...
Pelgi (225Ac-macropa-pelgifatamab)
A Study to Learn How Safe the Study Treatment Actinium-225-macropa-pelgifatamab (BAY3546828) is, How it Affects the Body, How it Moves In...